Codexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco

REDWOOD CITY, Calif., April 05, 2018 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at the H.C. Wainwright Global Life Sciences Conference on Tuesday, April 10, 2018 at 9:50 a.m. Central European time. The conference is being held at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.

A live webcast and replay of the presentation will be available on the Investors section of the company’s website, http://ir.codexis.com/.

About Codexis, Inc.

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver^® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial scale implementations of biocatalytic processes.

Contacts: 
Investors
LHA Investor Relations
Jody Cain, 310-691-7100
[email protected]